Follow the people · Insider
David D. O'Toole
David D. O'Toole files insider transactions with the SEC as a cfo of AVITA Medical (RCEL). We hold 5 disclosed purchases and sales filed since 5 May 2010, 1 of them in the last 90 days.
- Files forRCEL
- Disclosed buys and sells5 in all, 1 in the last 90 days
- Last disclosure24 August 2026
Positions held
6 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 15 June 2023 — 12 June 2026CFO · AVITA Medical (RCEL)46 Form 4 lines · source: SEC Form 4
- Filed 12 September 2017 — 2 March 2023Chief Financial Officer · Opiant Pharmaceuticals (OPNT)36 Form 4 lines · source: SEC Form 4
- Filed 12 November 2014 — 19 April 2017Director · Capnia (CAPN)13 Form 4 lines · source: SEC Form 4
- Filed 10 September 2012 — 4 September 2013SVP & Chief Financial Officer · Codexis (CDXS)9 Form 4 lines · source: SEC Form 4
- Filed 10 April 2012 — 29 May 2012Director · Medicinova (MNOV)2 Form 4 lines · source: SEC Form 4
- Filed 4 May 2010 — 2 February 2012VP and Chief Financial Officer · Response Genetics (RGDX)4 Form 4 lines · source: SEC Form 4
Everything they disclosed
110 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 2,000 shares of AVITA MedicalSEC Form 424 August 2026Common Stock · traded 12 June 2026 · filed 24 August 2026
- was granted 2,000 shares of AVITA MedicalSEC Form 412 June 2026Common Stock · traded 12 June 2026 · filed 12 June 2026
- was granted 5,000 shares of AVITA MedicalSEC Form 41 June 2026Common Stock · traded 29 May 2026 · filed 1 June 2026
- ▲ bought on the open market 2,000 shares of AVITA MedicalSEC Form 420 May 2026Common Stock · traded 20 May 2026 · filed 20 May 2026
- ▲ bought on the open market 2,000 shares of AVITA MedicalSEC Form 419 May 2026Common Stock · traded 19 May 2026 · filed 19 May 2026
- ▲ bought on the open market 1,800 shares of AVITA MedicalSEC Form 411 March 2026Common Stock · traded 11 March 2026 · filed 11 March 2026
- ▲ bought on the open market 1,800 shares of AVITA MedicalSEC Form 411 March 2026Common Stock · traded 11 March 2026 · filed 11 March 2026
- ▲ bought on the open market 3,000 shares of AVITA MedicalSEC Form 423 February 2026Common Stock · traded 19 February 2026 · filed 23 February 2026
- ▲ bought on the open market 3,000 shares of AVITA MedicalSEC Form 423 February 2026Common Stock · traded 19 February 2026 · filed 23 February 2026
- was granted 105,470 shares of AVITA MedicalSEC Form 419 February 2026Common Stock · traded 18 February 2026 · filed 19 February 2026
- was granted 155,510 shares of AVITA Medical (a derivative holding)SEC Form 419 February 2026Stock Options (Right to Buy) · traded 18 February 2026 · filed 19 February 2026
- was granted 155,510 shares of AVITA Medical (a derivative holding)SEC Form 419 February 2026Stock Options (Right to Buy) · traded 18 February 2026 · filed 19 February 2026
- was granted 105,470 shares of AVITA MedicalSEC Form 419 February 2026Common Stock · traded 18 February 2026 · filed 19 February 2026
- ▲ bought on the open market 2,000 shares of AVITA MedicalSEC Form 426 August 2025Common Stock · traded 26 August 2025 · filed 26 August 2025
- ▲ bought on the open market 2,000 shares of AVITA MedicalSEC Form 412 August 2025Common Stock · traded 12 August 2025 · filed 12 August 2025
- was granted 1,923 shares of AVITA MedicalSEC Form 42 June 2025Common Stock · traded 30 May 2025 · filed 2 June 2025
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 420 February 2025Common Stock · traded 20 February 2025 · filed 20 February 2025
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 419 February 2025Common Stock · traded 19 February 2025 · filed 19 February 2025
- was granted 150,000 shares of AVITA Medical (a derivative holding)SEC Form 422 January 2025Stock Options (Right to Buy) · traded 21 January 2025 · filed 22 January 2025
- was granted 785 shares of AVITA MedicalSEC Form 45 December 2024Common Stock · traded 29 November 2024 · filed 5 December 2024
- ▲ bought on the open market 475 shares of AVITA MedicalSEC Form 45 December 2024Common Stock · traded 5 December 2024 · filed 5 December 2024
- ▲ bought on the open market 500 shares of AVITA MedicalSEC Form 45 December 2024Common Stock · traded 5 December 2024 · filed 5 December 2024
- ▲ bought on the open market 500 shares of AVITA MedicalSEC Form 43 June 2024Common Stock · traded 30 May 2024 · filed 3 June 2024
- ▲ bought on the open market 500 shares of AVITA MedicalSEC Form 43 June 2024Common Stock · traded 30 May 2024 · filed 3 June 2024
- was granted 2,240 shares of AVITA MedicalSEC Form 43 June 2024Common Stock · traded 31 May 2024 · filed 3 June 2024
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 428 February 2024Common Stock · traded 28 February 2024 · filed 28 February 2024
- ▲ bought on the open market 250 shares of AVITA MedicalSEC Form 428 February 2024Common Stock · traded 28 February 2024 · filed 28 February 2024
- was granted 125,000 shares of AVITA Medical (a derivative holding)SEC Form 45 January 2024Stock Options (Right to Buy) · traded 3 January 2024 · filed 5 January 2024
- ▲ bought on the open market 950 shares of AVITA MedicalSEC Form 412 December 2023Common Stock · traded 12 December 2023 · filed 12 December 2023
- was granted 1,034 shares of AVITA MedicalSEC Form 44 December 2023Common Stock · traded 30 November 2023 · filed 4 December 2023
- ▲ bought on the open market 500 shares of AVITA MedicalSEC Form 44 December 2023Common Stock · traded 1 December 2023 · filed 4 December 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 421 November 2023Common Stock · traded 21 November 2023 · filed 21 November 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 421 November 2023Common Stock · traded 21 November 2023 · filed 21 November 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 416 November 2023Common Stock · traded 16 November 2023 · filed 16 November 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 416 November 2023Common Stock · traded 15 November 2023 · filed 16 November 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 415 November 2023Common Stock · traded 14 November 2023 · filed 15 November 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 415 November 2023Common Stock · traded 15 November 2023 · filed 15 November 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 416 August 2023Common Stock · traded 16 August 2023 · filed 16 August 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 416 August 2023Common Stock · traded 16 August 2023 · filed 16 August 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 415 August 2023Common Stock · traded 15 August 2023 · filed 15 August 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 415 August 2023Common Stock · traded 15 August 2023 · filed 15 August 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 415 August 2023Common Stock · traded 15 August 2023 · filed 15 August 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 415 August 2023Common Stock · traded 15 August 2023 · filed 15 August 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 415 August 2023Common Stock · traded 15 August 2023 · filed 15 August 2023
- ▲ bought on the open market 1,000 shares of AVITA MedicalSEC Form 421 June 2023Common Stock · traded 20 June 2023 · filed 21 June 2023
- was granted 150,000 shares of AVITA Medical (a derivative holding)SEC Form 416 June 2023Stock Options (Right to Buy) · traded 15 June 2023 · filed 16 June 2023
- returned to the issuer 33,000 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 43 March 2023Stock Option (right to buy) · traded 2 March 2023 · filed 3 March 2023
- returned to the issuer 8,250 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 43 March 2023Common Stock · traded 2 March 2023 · filed 3 March 2023
- returned to the issuer 10,750 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 43 March 2023Stock Option (right to buy) · traded 2 March 2023 · filed 3 March 2023
- returned to the issuer 22,512 shares of Opiant PharmaceuticalsSEC Form 43 March 2023Common Stock · traded 2 March 2023 · filed 3 March 2023
- returned to the issuer 11,736 shares of Opiant PharmaceuticalsSEC Form 43 March 2023Common Stock · traded 2 March 2023 · filed 3 March 2023
- was granted 2,000 shares of Opiant PharmaceuticalsSEC Form 43 March 2023Common Stock · traded 2 March 2023 · filed 3 March 2023
- returned to the issuer 2,000 shares of Opiant PharmaceuticalsSEC Form 43 March 2023Common Stock · traded 2 March 2023 · filed 3 March 2023
- ▼ sold on the open market 541 shares of Opiant PharmaceuticalsSEC Form 431 January 2023Common Stock · traded 27 January 2023 · filed 31 January 2023
- ▼ sold on the open market 415 shares of Opiant PharmaceuticalsSEC Form 49 January 2023Common Stock · traded 9 January 2023 · filed 9 January 2023
- ▼ sold on the open market 1,600 shares of Opiant PharmaceuticalsSEC Form 45 January 2023Common Stock · traded 5 January 2023 · filed 5 January 2023
- ▼ sold on the open market 779 shares of Opiant PharmaceuticalsSEC Form 415 July 2022Common Stock · traded 14 July 2022 · filed 15 July 2022
- was granted 2,000 shares of Opiant PharmaceuticalsSEC Form 429 June 2022Common Stock · traded 27 June 2022 · filed 29 June 2022
- ▼ sold on the open market 432 shares of Opiant PharmaceuticalsSEC Form 412 January 2022Common Stock · traded 10 January 2022 · filed 12 January 2022
- was granted 12,000 shares of Opiant PharmaceuticalsSEC Form 45 January 2022Common Stock · traded 4 January 2022 · filed 5 January 2022
- ▲ bought on the open market 179 shares of Opiant PharmaceuticalsSEC Form 415 September 2021Common Stock · traded 14 September 2021 · filed 15 September 2021
- ▲ bought on the open market 21 shares of Opiant PharmaceuticalsSEC Form 415 September 2021Common Stock · traded 14 September 2021 · filed 15 September 2021
- ▲ bought on the open market 600 shares of Opiant PharmaceuticalsSEC Form 416 August 2021Common Stock · traded 16 August 2021 · filed 16 August 2021
- was granted 2,450 shares of Opiant PharmaceuticalsSEC Form 427 January 2021Common Stock · traded 26 January 2021 · filed 27 January 2021
- was granted 5,400 shares of Opiant PharmaceuticalsSEC Form 427 January 2021Common Stock · traded 26 January 2021 · filed 27 January 2021
- was granted 10,750 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 427 January 2021Stock Option (right to buy) · traded 26 January 2021 · filed 27 January 2021
- ▲ bought on the open market 1,000 shares of Opiant PharmaceuticalsSEC Form 411 June 2020Common Stock · traded 11 June 2020 · filed 11 June 2020
- ▲ bought on the open market 1,000 shares of Opiant PharmaceuticalsSEC Form 426 May 2020Common Stock · traded 26 May 2020 · filed 26 May 2020
- was granted 8,250 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 49 January 2020Common Stock · traded 7 January 2020 · filed 9 January 2020
- was granted 4,150 shares of Opiant PharmaceuticalsSEC Form 49 January 2020Common Stock · traded 7 January 2020 · filed 9 January 2020
- ▲ bought on the open market 100 shares of Opiant PharmaceuticalsSEC Form 426 November 2019Common Stock · traded 26 November 2019 · filed 26 November 2019
- ▲ bought on the open market 1,000 shares of Opiant PharmaceuticalsSEC Form 415 November 2019Common Stock · traded 15 November 2019 · filed 15 November 2019
- ▲ bought on the open market 100 shares of Opiant PharmaceuticalsSEC Form 415 November 2019Common Stock · traded 15 November 2019 · filed 15 November 2019
- ▲ bought on the open market 1,000 shares of Opiant PharmaceuticalsSEC Form 415 August 2019Common Stock · traded 15 August 2019 · filed 15 August 2019
- ▲ bought on the open market 1,000 shares of Opiant PharmaceuticalsSEC Form 413 August 2019Common Stock · traded 13 August 2019 · filed 13 August 2019
- was granted 33,000 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 44 January 2019Stock Option (right to buy) · traded 3 January 2019 · filed 4 January 2019
- ▲ bought on the open market 15 shares of Opiant PharmaceuticalsSEC Form 414 August 2018Common Stock · traded 14 August 2018 · filed 14 August 2018
- ▲ bought on the open market 1,000 shares of Opiant PharmaceuticalsSEC Form 414 August 2018Common Stock · traded 14 August 2018 · filed 14 August 2018
- ▲ bought on the open market 2,000 shares of Opiant PharmaceuticalsSEC Form 416 May 2018Common Stock · traded 16 May 2018 · filed 16 May 2018
- ▲ bought on the open market 3,000 shares of Opiant PharmaceuticalsSEC Form 414 May 2018Common Stock · traded 11 May 2018 · filed 14 May 2018
- was granted 13,200 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 48 January 2018Stock Option (right to buy) · traded 4 January 2018 · filed 8 January 2018
- was granted 150,000 shares of Opiant Pharmaceuticals (a derivative holding)SEC Form 414 September 2017Stock Option (right to buy) · traded 12 September 2017 · filed 14 September 2017
- was granted 354,945 shares of Capnia (a derivative holding)SEC Form 424 April 2017Employee stock option (right to buy) · traded 19 April 2017 · filed 24 April 2017
- ▲ bought on the open market 2,000 shares of CapniaSEC Form 419 August 2016Common Stock · traded 18 August 2016 · filed 19 August 2016
- ▲ bought on the open market 10,000 shares of CapniaSEC Form 418 August 2016Common Stock · traded 17 August 2016 · filed 18 August 2016
- was granted 90,840 shares of Capnia (a derivative holding)SEC Form 410 June 2016Employee stock option (right to buy) · traded 8 June 2016 · filed 10 June 2016
- ▲ bought on the open market 5,000 shares of CapniaSEC Form 416 May 2016Common Stock · traded 12 May 2016 · filed 16 May 2016
- was granted 60,000 shares of Capnia (a derivative holding)SEC Form 411 January 2016Employee Stock Option · traded 10 January 2016 · filed 11 January 2016
- ▲ bought on the open market 5,000 shares of CapniaSEC Form 417 November 2015Common Stock · traded 17 November 2015 · filed 17 November 2015
- ▲ bought on the open market 7,500 shares of CapniaSEC Form 414 September 2015Common Stock · traded 14 September 2015 · filed 14 September 2015
- ▲ bought on the open market 10,000 shares of CapniaSEC Form 412 August 2015Common Stock · traded 11 August 2015 · filed 12 August 2015
- was granted 30,000 shares of Capnia (a derivative holding)SEC Form 419 May 2015Employee Stock Option · traded 15 May 2015 · filed 19 May 2015
- ▲ bought on the open market 5,250 shares of CapniaSEC Form 416 March 2015Common Stock · traded 13 March 2015 · filed 16 March 2015
- was granted 32,443 shares of Capnia (a derivative holding)SEC Form 413 January 2015Employee Stock Option · traded 11 January 2015 · filed 13 January 2015
- was granted 129,771 shares of Capnia (a derivative holding)SEC Form 414 November 2014Employee Stock Option · traded 12 November 2014 · filed 14 November 2014
- had shares withheld for tax on 4,697 shares of CodexisSEC Form 46 September 2013Common Stock · traded 4 September 2013 · filed 6 September 2013
- ▲ bought on the open market 10,000 shares of CodexisSEC Form 45 March 2013Common Stock · traded 4 March 2013 · filed 5 March 2013
- was granted 45,384 shares of CodexisSEC Form 428 January 2013Common Stock · traded 24 January 2013 · filed 28 January 2013
- was granted 76,022 shares of Codexis (a derivative holding)SEC Form 428 January 2013Stock Option (Right to Buy) · traded 24 January 2013 · filed 28 January 2013
- ▲ bought on the open market 5,000 shares of CodexisSEC Form 414 November 2012Common Stock · traded 12 November 2012 · filed 14 November 2012
- ▲ bought on the open market 2,500 shares of CodexisSEC Form 414 September 2012Common Stock · traded 13 September 2012 · filed 14 September 2012
- ▲ bought on the open market 2,500 shares of CodexisSEC Form 414 September 2012Common Stock · traded 14 September 2012 · filed 14 September 2012
- was granted 200,000 shares of Codexis (a derivative holding)SEC Form 412 September 2012Stock Option (Right to Buy) · traded 10 September 2012 · filed 12 September 2012
- was granted 50,000 shares of CodexisSEC Form 412 September 2012Common Stock · traded 10 September 2012 · filed 12 September 2012
- ▲ bought on the open market 5,000 shares of MedicinovaSEC Form 430 May 2012Common Stock · traded 29 May 2012 · filed 30 May 2012
- was granted 15,000 shares of Medicinova (a derivative holding)SEC Form 412 April 2012Stock Option (Right to Buy) · traded 10 April 2012 · filed 12 April 2012
- ▲ bought on the open market 1,000 shares of Response GeneticsSEC Form 46 February 2012Common Stock, par value $0.01 per share · traded 2 February 2012 · filed 6 February 2012
- was granted 30,000 shares of Response Genetics (a derivative holding)SEC Form 416 December 2011Stock Option (right to buy) · traded 14 December 2011 · filed 16 December 2011
- was granted 30,000 shares of Response Genetics (a derivative holding)SEC Form 414 April 2011Stock Option (right to buy) · traded 12 April 2011 · filed 14 April 2011
- was granted 100,000 shares of Response Genetics (a derivative holding)SEC Form 45 May 2010Stock Option (right to buy) · traded 4 May 2010 · filed 5 May 2010
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.